| Mrs Holly Hansom Quarles, PT | |
|
2100 Exeter Rd, Germantown, TN 38138-3922 | |
| (901) 757-3458 | |
| (901) 757-3497 |
| Full Name | Mrs Holly Hansom Quarles |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 2100 Exeter Rd, Germantown, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154441582 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 5524 (Tennessee) | Primary |
| Provider Name | Ave Maria Home |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1831250604 PECOS PAC ID: 2365518909 Enrollment ID: O20211028001255 |
News Archive
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced the closing of its first financing, an $8 million private placement of the company's Series A Preferred Stock. Led by 5AM Ventures, other investors participating in the financing included Takeda Research Investment and Roche Venture Fund.
Patients who undergo brain surgery to treat aneurysms are at risk for permanent brain damage, but a protective cooling system is now being tested at Rush University Medical Center to reduce or eliminate this risk.
Researchers from Aalto University have found the mechanism of action for cancer-cell-killing peptides. This breakthrough is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, and infections caused by multi-resistant bacteria.
The U.S. Department of Labor's Occupational Safety and Health Administration (OSHA) has unveiled new safety and health guidance that will help healthcare workers and their employers prepare for a possible influenza pandemic.
› Verified 1 days ago
| Provider Name | Aegis Group Practice Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1174308647 PECOS PAC ID: 5193036432 Enrollment ID: O20231018002544 |
News Archive
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced the closing of its first financing, an $8 million private placement of the company's Series A Preferred Stock. Led by 5AM Ventures, other investors participating in the financing included Takeda Research Investment and Roche Venture Fund.
Patients who undergo brain surgery to treat aneurysms are at risk for permanent brain damage, but a protective cooling system is now being tested at Rush University Medical Center to reduce or eliminate this risk.
Researchers from Aalto University have found the mechanism of action for cancer-cell-killing peptides. This breakthrough is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, and infections caused by multi-resistant bacteria.
The U.S. Department of Labor's Occupational Safety and Health Administration (OSHA) has unveiled new safety and health guidance that will help healthcare workers and their employers prepare for a possible influenza pandemic.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Holly Hansom Quarles, PT 2100 Exeter Rd, Germantown, TN 38138-3922 Ph: (901) 757-3458 | Mrs Holly Hansom Quarles, PT 2100 Exeter Rd, Germantown, TN 38138-3922 Ph: (901) 757-3458 |
News Archive
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced the closing of its first financing, an $8 million private placement of the company's Series A Preferred Stock. Led by 5AM Ventures, other investors participating in the financing included Takeda Research Investment and Roche Venture Fund.
Patients who undergo brain surgery to treat aneurysms are at risk for permanent brain damage, but a protective cooling system is now being tested at Rush University Medical Center to reduce or eliminate this risk.
Researchers from Aalto University have found the mechanism of action for cancer-cell-killing peptides. This breakthrough is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, and infections caused by multi-resistant bacteria.
The U.S. Department of Labor's Occupational Safety and Health Administration (OSHA) has unveiled new safety and health guidance that will help healthcare workers and their employers prepare for a possible influenza pandemic.
› Verified 1 days ago
Residential Teletherapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8885 Three Chimneys Dr. E, Germantown, TN 38138 Phone: 912-667-7874 | |
Stacey Leanne Howell, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2281 Kimbrough Woods Pl, Germantown, TN 38139 Phone: 662-769-0622 | |
901 Physical Therapy, Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Regents Walk, Germantown, TN 38138 Phone: 901-605-9687 | |
Kristen Glancey, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7550 Wolf River Blvd Ste 101, Germantown, TN 38138 Phone: 901-756-4818 Fax: 901-756-4819 | |
Mrs. Kelly Diane Lee, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1400 S Germantown Rd, Germantown, TN 38138 Phone: 901-759-3180 Fax: 901-759-3198 | |
Ms. Jenny L Doza, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2100 Exeter Rd, Germantown, TN 38138 Phone: 901-757-1350 Fax: 901-757-3496 | |
Jessica Rhoades, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1400 S Germantown Rd, Germantown, TN 38138 Phone: 901-759-3180 |